Cargando…

Characterization of immune checkpoint inhibitor-associated fulminant type 1 diabetes associated with autoantibody status and ethnic origin

OBJECTIVE: Fulminant type 1 diabetes may uniquely occur as a fatal adverse event during immune checkpoint inhibitor (ICI) therapy. We investigated the clinical and immunological characteristics of ICI-associated fulminant type 1 diabetes (IFD). RESEARCH DESIGN AND METHODS: We enrolled 80 patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Junlin, Luo, Shuoming, Yin, Wenfeng, Guo, Keyu, Xiang, Yufei, Li, Xia, Liu, Zhenqi, Zhou, Zhiguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702060/ https://www.ncbi.nlm.nih.gov/pubmed/36451831 http://dx.doi.org/10.3389/fimmu.2022.968798

Ejemplares similares

Identification of hsa_circRNA_100632 as a novel molecular biomarker for fulminant type 1 diabetes
por: Yin, Wenfeng, et al.
Publicado: (2023)

Latent autoimmune diabetes in adults in China
por: Qiu, Junlin, et al.
Publicado: (2022)

Association of the rs1990760, rs3747517, and rs10930046 polymorphisms in the IFIH1 gene with susceptibility to autoimmune diseases: a meta-analysis
por: Xiao, Zilin, et al.
Publicado: (2023)

Case Report: Fulminant Celiac Disease With Combination Immune Checkpoint Therapy
por: Falade, Ayo S., et al.
Publicado: (2022)

Immune checkpoint inhibitors-related pancreatitis with fulminant type 1 diabetes mellitus: case report and literature review
por: Fang, Wei, et al.
Publicado: (2023)

Fulminant type 1 diabetes after COVID-19 vaccination
por: Tang, Xiaohan, et al.
Publicado: (2022)

Tropomyosin autoantibodies associated with checkpoint inhibitor myositis
por: Zaenker, Pauline, et al.
Publicado: (2020)

Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune related adverse events
por: Müller-Jensen, Leonie, et al.
Publicado: (2023)

Case Report: Simultaneous Hyperprogression and Fulminant Myocarditis in a Patient With Advanced Melanoma Following Treatment With Immune Checkpoint Inhibitor Therapy
por: Barham, Whitney, et al.
Publicado: (2021)

Glutamic acid decarboxylase autoantibodies are dominant but insufficient to identify most Chinese with adult-onset non-insulin requiring autoimmune diabetes: LADA China study 5
por: Xiang, Yufei, et al.
Publicado: (2015)

Autoantibody Landscape Revealed by Wet Protein Array: Sum of Autoantibody Levels Reflects Disease Status
por: Matsuda, Kazuki M., et al.
Publicado: (2022)

Thyroid Autoantibodies Display both “Original Antigenic Sin” and Epitope Spreading
por: McLachlan, Sandra M., et al.
Publicado: (2017)

Maternal synapsin autoantibodies are associated with neurodevelopmental delay
por: Bünger, Isabel, et al.
Publicado: (2023)

Plasma-derived exosomal mRNA profiles associated with type 1 diabetes mellitus
por: Fan, Wenqi, et al.
Publicado: (2022)

Altered Tim-1 and IL-10 Expression in Regulatory B Cell Subsets in Type 1 Diabetes
por: Liu, Yikai, et al.
Publicado: (2021)

Cutaneous manifestations associated with immune checkpoint inhibitors
por: Watanabe, Tomoya, et al.
Publicado: (2023)

Checkpoint inhibitor immune-related adverse events: A focused review on autoantibodies and B cells as biomarkers, advancements and future possibilities
por: Taylor, John, et al.
Publicado: (2023)

The NLRP3 Inflammasome and Its Role in T1DM
por: Sun, Xiaoxiao, et al.
Publicado: (2020)

Emerging Roles of Exosomes in T1DM
por: Pang, Haipeng, et al.
Publicado: (2020)

Protein ubiquitination in T cell development
por: Zhong, Ting, et al.
Publicado: (2022)

Novel Roles of the Tim Family in Immune Regulation and Autoimmune Diseases
por: Liu, Yikai, et al.
Publicado: (2021)

PADI2 Polymorphisms Are Significantly Associated With Rheumatoid Arthritis, Autoantibodies Serologic Status and Joint Damage in Women from Southern Mexico
por: Guzmán-Guzmán, Iris Paola, et al.
Publicado: (2021)

Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?
por: Didier, Kevin, et al.
Publicado: (2018)

Delayed Diagnosis and Recovery of Fulminant Immune Checkpoint Inhibitor-Associated Myocarditis on VA-ECMO Support
por: Ramayya, Tarun, et al.
Publicado: (2022)

Immune Checkpoint Inhibitor-Associated Colitis: From Mechanism to Management
por: Tang, Liansha, et al.
Publicado: (2021)

Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2019)

Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides
por: Lamprecht, Peter, et al.
Publicado: (2018)

A case report and literature review of immune checkpoint inhibitor-associated pneumonia caused by penpulimab
por: Gao, Rongmao, et al.
Publicado: (2023)

Immune Response to Enterococcus gallinarum in Lupus Patients Is Associated With a Subset of Lupus-Associated Autoantibodies
por: Bagavant, Harini, et al.
Publicado: (2021)

Editorial: Autoantibodies
por: Holmdahl, Rikard, et al.
Publicado: (2019)

Frequency, Immunogenetics, and Clinical Characteristics of Latent Autoimmune Diabetes in China (LADA China Study): A Nationwide, Multicenter, Clinic-Based Cross-Sectional Study
por: Zhou, Zhiguang, et al.
Publicado: (2013)

Ophthalmic immune-related adverse events associated with immune checkpoint inhibitors
por: Gan, Linyang, et al.
Publicado: (2023)

Immune Checkpoint Targeted Therapy in Glioma: Status and Hopes
por: Qi, Yangzhi, et al.
Publicado: (2020)

Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis
por: Darrah, Erika, et al.
Publicado: (2018)

Association of immune-related adverse events induced by nivolumab with a battery of autoantibodies
por: Les, Iñigo, et al.
Publicado: (2021)

Immunopsychiatry – Innovative Technology to Characterize Disease Activity in Autoantibody-Associated Psychiatric Diseases
por: Hansen, Niels
Publicado: (2022)

Immune Checkpoint-Related Gene Polymorphisms Are Associated With Primary Immune Thrombocytopenia
por: Wang, Shuwen, et al.
Publicado: (2021)

Immune checkpoint inhibitor–associated myocarditis: a systematic analysis of case reports
por: Wang, Caie, et al.
Publicado: (2023)

Autoantibodies in Systemic Vasculitis
por: Silva de Souza, Alexandre Wagner
Publicado: (2015)

Environment, Autoantibodies, and Autoimmunity
por: Pollard, Kenneth Michael
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1mv9hj5skamkujr31m5i5vhs8c